Correlation Between FibroBiologics Common and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both FibroBiologics Common and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroBiologics Common and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroBiologics Common Stock and enGene Holdings Common, you can compare the effects of market volatilities on FibroBiologics Common and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroBiologics Common with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroBiologics Common and EnGene Holdings.
Diversification Opportunities for FibroBiologics Common and EnGene Holdings
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FibroBiologics and EnGene is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding FibroBiologics Common Stock and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and FibroBiologics Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroBiologics Common Stock are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of FibroBiologics Common i.e., FibroBiologics Common and EnGene Holdings go up and down completely randomly.
Pair Corralation between FibroBiologics Common and EnGene Holdings
Given the investment horizon of 90 days FibroBiologics Common Stock is expected to under-perform the EnGene Holdings. In addition to that, FibroBiologics Common is 2.43 times more volatile than enGene Holdings Common. It trades about -0.22 of its total potential returns per unit of risk. enGene Holdings Common is currently generating about 0.11 per unit of volatility. If you would invest 800.00 in enGene Holdings Common on April 4, 2024 and sell it today you would earn a total of 99.00 from holding enGene Holdings Common or generate 12.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
FibroBiologics Common Stock vs. enGene Holdings Common
Performance |
Timeline |
FibroBiologics Common |
enGene Holdings Common |
FibroBiologics Common and EnGene Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FibroBiologics Common and EnGene Holdings
The main advantage of trading using opposite FibroBiologics Common and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroBiologics Common position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.FibroBiologics Common vs. Equillium | FibroBiologics Common vs. Kineta Inc | FibroBiologics Common vs. DiaMedica Therapeutics | FibroBiologics Common vs. Valneva SE ADR |
EnGene Holdings vs. Entero Therapeutics, | EnGene Holdings vs. Eupraxia Pharmaceuticals Common | EnGene Holdings vs. CERo Therapeutics Holdings | EnGene Holdings vs. FibroBiologics Common Stock |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets |